10
Participants
Start Date
April 30, 2008
Primary Completion Date
February 28, 2010
Study Completion Date
May 31, 2010
Entecavir with continued standard of care antiretroviral therapy
1 mg by mouth daily
continued standard of care with tenofovir in addition to emtricitabine or lamivudine
continued standard of care with tenofovir in addition to emtricitabine or lamivudine
San Francisco General HIV Clinical Trials Group, San Francisco
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
University of California, San Francisco
OTHER